Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 6, 2008, Pages 531-542

  O'Donnell, Siobhan ^a   Moher, David ^b   Thomas, Kelli ^a   Hanley, David A ^c   Cranney, Ann ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Alfacalcidol; Calcitriol; Falls; Fractures; Systematic review

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCIUM; PLACEBO; VITAMIN D; 1-HYDROXYCHOLECALCIFEROL; BONE DENSITY CONSERVATION AGENT; HYDROXYCOLECALCIFEROL; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FALLING; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VERTEBRA FRACTURE; FRACTURE; MEDLINE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACCIDENTAL FALLS; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; CALCIUM; FRACTURES, BONE; HUMANS; HYDROXYCHOLECALCIFEROLS; MEDLINE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 58149261904     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0868-y     Document Type: Review

References (50)

1. NIH consensus development panel on osteoporosis preventiondiagnosis 2001 Osteoporosis prevention, diagnosis, prophylaxis and treatment JAMA 285 785 795
2. O. Johnell J.A. Kanis 2004 An estimate of the worldwide prevalence, mortality and disability associated with hip fracture Osteoporos Int 15 11 897 902
3. A.N. Tosteson S.E. Gabriel M.R. Grove M.M. Moncur T.S. Kneeland L.J. Melton III 2001 Impact of hip and vertebral fractures on quality-adjusted life years Osteoporos Int 12 12 1042 1049
4. J.A. Cauley D.E. Thompson K.C. Ensrud J.C. Scott D. Black 2000 Risk of mortality following clinical fractures Osteoporos Int 11 7 556 561
5. T. Youm K.J. Koval F.J. Kummer J.D. Zuckerman 1999 Do all hip fractures result from a fall? Am J Orthop 28 3 190 194
6. B. Dawson-Hughes S.S. Harris E.A. Krall G.E. Dallal 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 10 670 676
7. H.A. Bischoff-Ferrari B. Dawson-Hughes W.C. Willett H.B. Staehelin M.G. Bazemore R.Y. Zee J.B. Wong 2004 Effect of vitamin D on falls: a meta-analysis JAMA 291 16 1999 2006
8. W.B. Grant M.F. Holick 2005 Benefits and requirements of vitamin D for optimal health: a review Altern Med Rev 10 2 94 111
9. H. Reichel H.P. Koeffler A.W. Norman 1989 The role of the vitamin D endocrine system in health and disease N Engl J Med 320 15 980 991
10. 3) and calcium in osteoporosis Clin Orthop 300 241 247
11. 3 Int J Vitam Nutr Res 68 1 36 41
12. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL (2005) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis [update of Cochrane Database Syst Rev. 2001;(1):CD000227; PMID: 11279685]. Cochrane Database Syst Rev (3):CD000227
13. H.J. Hauselmann R. Rizzoli 2003 A comprehensive review of treatments for postmenopausal osteoporosis Osteoporos Int 14 1 2 12
14. N.K. Latham C.S. Anderson I.R. Reid 2003 Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review J Am Geriatr Soc 51 9 1219 1226
15. E. Papadimitropoulos G. Wells B. Shea W. Gillespie B. Weaver N. Zytaruk A. Cranney J. Adachi P. Tugwell R. Josse C. Greenwood G. Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women Endocr Rev 23 4 560 569
16. F. Richy E. Schacht O. Bruyere O. Ethgen M. Gourlay J.Y. Reginster 2005 Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative metaanalysis Calcif Tissue Int 76 3 176 186
17. F. Richy O. Ethgen O. Bruyere J.Y. Reginster 2004 Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate Osteoporos Int 15 4 301 310
18. D.G. Seeley W.S. Browner M.C. Nevitt H.K. Genant J.C. Scott S.R. Cummings 1991 Which fractures are associated with low appendicular bone mass in elderly women Ann Intern Med 115 837 842
19. K.L. Stone D.G. Seeley L.Y. Lui J.A. Cauley K. Ensrud W.S. Browner M.C. Nevitt S.R. Cummings 2003 BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures J Bone Miner Res 18 11 1947 1954
20. J.A. Berlin 1997 Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group Lancet 350 9072 185 186
21. A.R. Jadad R.A. Moore D. Carroll C. Jenkinson D.J. Reynolds D.J. Gavaghan H.J. McQuay 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1 12
22. K.F. Schulz I. Chalmers R.J. Hayes D.G. Altman 1995 Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA 273 5 408 412
23. A. Cranney P. Tugwell G. Wells G. Guyatt 2002 Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology Endocr Rev 23 4 496 507
24. B. Shea G. Wells A. Cranney N. Zytaruk V. Robinson L. Griffith C. Hamel Z. Ortiz J. Peterson J. Adachi P. Tugwell G. Guyatt 2004 Calcium supplementation on bone loss in postmenopausal women Cochrane Database Syst Rev 1 CD004526
25. J.L. Fleiss 1993 The statistical basis of meta-analysis Stat Methods Med Res 2 2 121 145
26. J.P. Higgins S.G. Thompson 2002 Quantifying heterogeneity in a meta-analysis Stat Med 21 11 1539 1558
27. D.M. Black L. Palermo M.C. Nevitt H.K. Genant R. Epstein R. San Valentin S.R. Cummings 1995 Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures J Bone Miner Res 10 6 890 902
28. J.A. Sterne M. Egger 2001 Funnel plots for detecting bias in metaanalysis: guidelines on choice of axis J Clin Epidemiol 54 10 1046 1055
29. M. Egger S.G. Davey M. Schneider C. Minder 1997 Bias in meta-analysis detected by a simple, graphical test Br Med J 315 7109 629 634
30. D. Moher D.J. Cook S. Eastwood I. Olkin D. Rennie D.F. Stroup 1999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement Quality of reporting of meta-analyses. Lancet 354 9193 1896 1900
31. J.F. Aloia A. Vaswani J.K. Yeh K. Ellis S. Yasumura S.H. Cohn 1988 Calcitriol in the treatment of postmenopausal osteoporosis Am J Med 84 3pt1 401 408
32. 3, estradiol and placebo in postmenopausal osteoporosis Acta Vitaminol Enzymol 6 2 117 128
33. J.C. Gallagher B.L. Riggs R.R. Recker D. Goldgar 1989 The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency Proc Soc Exp Biol Med 191 3 287 292
34. J.C. Gallagher D. Goldgar 1990 Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomized controlled study Ann Intern Med 113 9 649 655
35. J.C. Gallagher S.E. Fowler J.R. Detter S.S. Sherman 2001 Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss J Clin Endocrinol Metab 86 8 3618 3628
36. 3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women Clin Orthop 192 215 221
37. Y. Ishida S. Kawai 2004 Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study Am J Med 117 8 549 555
38. 3 Calcif Tissue Int 65 1 16 22
39. S.M. Ott C.H. Chesnut III 1989 Calcitriol treatment is not effective in postmenopausal osteoporosis Ann Intern Med 110 4 267 274
40. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis Calcif Tissue Int 54 5 370 376
41. 3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study Endocr J 43 2 211 220
42. M.W. Tilyard G.F.S. Spears J. Thomson S. Dovey 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium N Engl J Med 326 6 357 362
43. T. Ushiroyama A. Ikeda M. Sakai T. Higashiyama M. Ueki 2001 Effects of the combined use of calcitonin and 1-alpha-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low dose calcitonin Maturitas 40 3 229 238
44. P.R. Ebeling J.D. Wark S. Yeung C. Poon N. Salehi G.C. Nicholson M.A. Kotowicz 2001 Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study J Clin Endocrinol Metab 86 9 4098 4103
45. L. Dukas H.A. Bischoff L.S. Lindpaintner E. Schacht D. Birkner-Binder T.N. Damm B. Thalmann H.B. Stahelin 2004 Alfacalcidol reduces the number of fallers in a communitydwelling elderly population with a minimum calcium intake of more than 500 mg daily J Am Geriatr Soc 52 2 230 236
46. H. Orimo E. Schacht 2005 The D-hormone analog alfacalcidol: the pioneer beyond the horizon of osteoporosis treatment J Rheumatol 32 76 4 10
47. E. Schacht F. Richy J.Y. Reginster 2005 The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures J Musculoskelet Neuronal Interact 5 3 273 284
48. D. Moher P. Fortin A.R. Jadad P. Juni T. Klassen J. Le Lorier A. Liberati K. Linde A. Penna 1996 Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews Lancet 347 8998 363 366
49. J.P. Ioannidis S.J. Evans P.C. Gøtzsche R.T. O'Neill D.G. Altman K. Schulz D. Moher CONSORT Group 2004 Better reporting of harms in randomized trials: an extension of the CONSORT statement Ann Intern Med 141 10 781 788
50. Higgins JPT, Green S (eds) (2006) Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6. In: The Cochrane Library, Issue 4. Wiley, Chichester, UK